focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Regulatory News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Mar 2022 07:00

RNS Number : 6733F
ReNeuron Group plc
23 March 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BF5G6K95

Issuer Name

RENEURON GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Spreadex LTD

City of registered office (if applicable)

St. Albans

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

21-Mar-2022

6. Date on which Issuer notified

22-Mar-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.734800

0.268700

1.003500

572650

Position of previous notification (if applicable)

0.734800

3.035000

3.769800

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BF5G6K95

419300

0.734800

Sub Total 8.A

419300

0.734800%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

CFD/Spreadbet

153350

0.268700

Sub Total 8.B1

153350

0.268700%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Alex Longmuir01727895161

12. Date of Completion

22-Mar-2022

13. Place Of Completion

UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEANDAADFAEFA
Date   Source Headline
12th Feb 20207:00 amRNSNotification of Major Holdings
7th Feb 20201:15 pmRNSNotification of Major Holdings
6th Feb 20209:51 amRNSNotification of Major Holdings
2nd Jan 20207:00 amRNSTotal Voting Rights
18th Dec 201912:10 pmRNSNotification of Major Holdings
16th Dec 20193:00 pmRNSNOTIFICATION OF MAJOR HOLDINGS
6th Dec 20197:00 amRNSInterim Results
18th Nov 20197:00 amRNSNotification of Interim Results
23rd Oct 20197:00 amRNSReNeuron's lead cell line shows further potential
17th Oct 20195:36 pmRNSNotification of Major Holdings
17th Oct 20193:21 pmRNSNotification of Major Holdings
14th Oct 20197:00 amRNSPositive clinical data presented at AAO meeting
2nd Oct 20194:40 pmRNSSecond Price Monitoring Extn
2nd Oct 20194:35 pmRNSPrice Monitoring Extension
2nd Oct 20197:00 amRNSClinical Update and Conference Presentations
12th Sep 201911:21 amRNSResult of AGM
10th Sep 20197:00 amRNSAGM Trading Update
2nd Sep 20197:00 amRNSBlock Listing Review and TVR
21st Aug 20197:00 amRNSAppointments to Scientific Advisory Board
14th Aug 20197:00 amRNSGrant-funded collaboration with exosome platform
2nd Aug 20194:00 pmRNSPosting of Annual Report and Notice of AGM
2nd Aug 20191:12 pmRNSNotification of Major Holdings
1st Aug 201911:50 amRNSTotal Voting Rights
17th Jul 20197:00 amRNSDirector/PDMR Interest in Shares & Share Options
16th Jul 20197:00 amRNSKey patent grants expand exosome IP portfolio
12th Jul 20197:00 amRNSSenior business development appointment
11th Jul 20197:00 amRNSPreliminary Results
8th Jul 20194:30 pmRNSNotification of Major Holdings
1st Jul 201911:00 amRNSPrice Monitoring Extension
1st Jul 20197:00 amRNSTotal Voting Rights
18th Jun 20194:01 pmRNSNotification of Major Holdings
18th Jun 20197:00 amRNSWebcast of Preliminary Results
14th Jun 201911:09 amRNSReNeuron wins Breakthrough of the Year Award
3rd Jun 20197:00 amRNSTotal Voting Rights
31st May 20197:00 amRNSJefferies 2019 Global Healthcare Conference
9th May 20195:05 pmRNSExercise of options, PDMR dealing and TVR
8th May 20197:00 amRNSYear-end update and results notification
2nd May 20193:43 pmRNSTotal Voting Rights
26th Apr 20194:40 pmRNSSecond Price Monitoring Extn
26th Apr 20194:35 pmRNSPrice Monitoring Extension
26th Apr 20197:00 amRNSClinical update and conference presentation
18th Apr 20193:40 pmRNSShare Purchases by Directors
12th Apr 20192:36 pmRNSExercise of Share Options and TVR
11th Apr 20194:31 pmRNSShare Purchases by Directors
10th Apr 20192:37 pmRNSDirector/PDMR Shares and Share Options
5th Apr 20197:00 amRNSReNeuron to present at UK investor conference
4th Apr 20197:00 amRNSClinical update and conference presentation
28th Mar 20192:05 pmRNSSecond Price Monitoring Extn
28th Mar 20192:00 pmRNSPrice Monitoring Extension
18th Mar 201912:00 pmRNSAlliance for Regenerative Medicine presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.